BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7536091)

  • 61. Effect of guidelines on primary care physician use of PSA screening: results from the Community Tracking Study Physician Survey.
    Guerra CE; Gimotty PA; Shea JA; Pagán JA; Schwartz JS; Armstrong K
    Med Decis Making; 2008; 28(5):681-9. PubMed ID: 18556635
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
    Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Do general practitioners use prostate-specific antigen as a screening test for early prostate cancer?
    Ward JE; Gupta L; Taylor NJ
    Med J Aust; 1998 Jul; 169(1):29-31. PubMed ID: 9695699
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Learning amid controversy: prostate cancer knowledge and screening practices among US medical students.
    Werny DM; Saraiya M; Carrera J; Coughlin SS; Frank E
    J Cancer Educ; 2008; 23(2):108-13. PubMed ID: 18569246
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions.
    Mercer SL; Goel V; Levy IG; Ashbury FD; Iverson DC; Iscoe NA
    Can J Public Health; 1997; 88(5):327-32. PubMed ID: 9401168
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey.
    Chan EC; Barry MJ; Vernon SW; Ahn C
    J Gen Intern Med; 2006 Mar; 21(3):257-9. PubMed ID: 16637825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preparing African-American men in community primary care practices to decide whether or not to have prostate cancer screening.
    Myers RE; Daskalakis C; Cocroft J; Kunkel EJ; Delmoor E; Liberatore M; Nydick RL; Brown ER; Gay RN; Powell T; Powell RL
    J Natl Med Assoc; 2005 Aug; 97(8):1143-54. PubMed ID: 16173330
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prostate cancer screening. What family physicians believe is best.
    Hicks RJ; Hamm RM; Bemben DA
    Arch Fam Med; 1995 Apr; 4(4):317-22. PubMed ID: 7711917
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Physician and patient predictors of health maintenance visits.
    Preisser JS; Cohen SJ; Wofford JL; Moran WP; Shelton BJ; McClatchey MW; Wolfe P
    Arch Fam Med; 1998; 7(4):346-51. PubMed ID: 9682688
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The accuracy of primary care patients' self-reports of prostate-specific antigen testing.
    Volk RJ; Cass AR
    Am J Prev Med; 2002 Jan; 22(1):56-8. PubMed ID: 11777680
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Determinants of prostate specific antigen screening test uptake in an urban community in North-Central Nigeria.
    Bello JO; Buhari T; Mohammed TO; Olanipekun HB; Egbuniwe AM; Fasiku OK; Wasiu R
    Afr Health Sci; 2019 Mar; 19(1):1665-1670. PubMed ID: 31148996
    [TBL] [Abstract][Full Text] [Related]  

  • 72. US men discussing prostate-specific antigen tests with a physician.
    McFall SL
    Ann Fam Med; 2006; 4(5):433-6. PubMed ID: 17003144
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network.
    Shah A; Polascik TJ; George DJ; Anderson J; Hyslop T; Ellis AM; Armstrong AJ; Ferrandino M; Preminger GM; Gupta RT; Lee WR; Barrett NJ; Ragsdale J; Mills C; Check DK; Aminsharifi A; Schulman A; Sze C; Tsivian E; Tay KJ; Patierno S; Oeffinger KC; Shah K
    J Gen Intern Med; 2021 Jan; 36(1):92-99. PubMed ID: 32875501
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Older Korean American men's prostate cancer screening behavior: the prime role of culture.
    Lee HY; Jung Y
    J Immigr Minor Health; 2013 Dec; 15(6):1030-7. PubMed ID: 23504334
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The problem with choice: what my mechanic taught me about PSA screening.
    Suss R
    Can Fam Physician; 2008 Sep; 54(9):1287-8. PubMed ID: 18791107
    [No Abstract]   [Full Text] [Related]  

  • 76. Association between Serum Triglycerides and Prostate Specific Antigen (PSA) among U.S. Males: National Health and Nutrition Examination Survey (NHANES), 2003-2010.
    Wei C; Tian L; Jia B; Wang M; Xiong M; Hu B; Deng C; Hou Y; Hou T; Yang X; Chen Z
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405939
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Approach to primary care follow-up of patients with prostate cancer.
    Wilkinson AN; Brundage MD; Siemens R
    Can Fam Physician; 2008 Feb; 54(2):204-10. PubMed ID: 18272636
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Changes in the uptake of screening for prostate cancer with prostate-specific antigen in Ontario between 2003 to 2012.
    Watson L
    Can Oncol Nurs J; 2020; 30(2):125-132. PubMed ID: 33118992
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
    Turner EL; Lane JA; Donovan JL; Davis MJ; Metcalfe C; Neal DE; Hamdy FC; Martin RM
    Int J Cancer; 2011 Jan; 128(2):440-6. PubMed ID: 20473853
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A patient-initiated system for preventive health care. A randomized trial in community-based primary care practices.
    Williams RB; Boles M; Johnson RE
    Arch Fam Med; 1998; 7(4):338-45. PubMed ID: 9682687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.